CommonWealth Magazine

Paul A. Hattis

Associate professor, Tufts University Medical School

Stories by Paul A. Hattis

I’ve got questions on Rep. Neal, Partners

Why did congressman buckle? Is outpatient expansion good for us?

Five takeaways from the Health Policy Commission hearing

Is the state’s cost benchmark in danger of breach?

Money for nothing

The wacky world of hospital reimbursement

What consumers deserve from Harvard Pilgrim-Tufts merger

Real cost savings and payment system innovation should be expected

Medicare for All interim steps

Focus for now on should be on market dysfunction issues

MassBIO’s drug pricing concerns don’t add up

Big pharma should stop making threats about leaving

Time for Tufts soul-searching on Purdue Pharma

Whatever probe uncovers should be released publicly

A pitch for socializing corporate health insurance premiums

High-salaried workers may need to pay more so lower-wage workers pay less

Partners is like a shark – always on the move

Let’s examine its growth strategies going forward

Are the Partners hospitals really partners?

The uneasy alliance of MGH and Brigham and Women’s

A Partners take on BI-Lahey merger

There could be some interesting side-effects

Why we’re voting no on Question 1

Evidence raises concerns on nurse-to-patient staffing ratios

Can we make the (bad) BI-Lahey merger work?

If conditions are the way to go, here are my suggestions

5 takeaways from the Beth Israel-Lahey merger review

Cost increases and lack of concern at Health Policy Commission are surprises

A letter to Larry Bacow

Three suggestions as you take over as Harvard president

House bill plays Robin Hood on health care

Introduces concept of ‘unwarranted factors’ of price variation

Health Policy Commission should do more

Agency should listen more and weigh ballot question evidence

Tracking hospital community investments

Progress has been made, but there’s still work to do

Four thoughts for the GIC

Is Partners gaming the system with Neighborhood Health?

What’s likely to happen with the Partners-Eye and Ear deal

A no is in order, but a conditional approval may be likely

5 takeaways from health cost trends hearings

Baker, Partners margins, and social determinants

Beth Israel-Lahey merger causing some jitters

Can this ‘second system’ be a true competitor to Partners?

Moving beyond health cost targets

A struggle for the soul of the Health Policy Commission

The Partners premium

Dissecting the tall tales of the state’s largest health care system

Could breakup of Partners be way to go?

A Mass General, Brigham divorce could make sense